Centre for Child and Adolescent Mental Health, Mental Health Services, Capital Region of Denmark, Glostrup, Denmark.
Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark.
Child Adolesc Ment Health. 2020 May;25(2):79-94. doi: 10.1111/camh.12360. Epub 2020 Jan 7.
The assessment of motor disturbances in antipsychotic-treated adolescent patients is often limited to the use of observer-based rating scales with interobserver variability. The objectives of this pilot study were to measure movement patterns associated with antipsychotic-induced parkinsonism in young patients with psychosis and initiating/treated with antipsychotics, using a computer application connected with the Microsoft Kinect sensor (Motorgame).
All participants were assessed by neurological examination, clinical side effect rating scales (Udvalg for Kliniske Undersøgelser Side Effect Rating Scale, Barnes Akathisia Rating Scale, Simpson Angus Scale (SAS), and Abnormal Involuntary Movement Scale), and the Motorgame. Furthermore, speed of information processing and motor speed with subtests from the Brief Assessment of Cognition in Schizophrenia test battery was assessed.
We included 21 adolescents with first-episode psychosis (62% treated with antipsychotics; males 38%; mean age 16 ± 1.4 years) and 69 healthy controls (males 36%; mean age 16 ± 1.5 years). Prolonged time of motor performance (TOMP) in the Motorgame was associated with higher SAS scores for arm dropping (p = .009). A consistent practice effect was detected (p < .001). We found no significant associations between TOMP and age, height, body weight, sex, antipsychotic dosage, or information processing speed.
We found an uncorrected significant association between prolonged TOMP and shoulder bradykinesia. The Motorgame was found useful in assessing parkinsonian symptoms in early-onset psychosis and accepted by participants. Future studies of larger cohorts, including patients with high scores in clinical motor side effect scales, are required to establish solid validity of the novel test.
评估抗精神病药物治疗的青少年患者的运动障碍通常仅限于使用观察者为基础的评定量表,其存在观察者间变异性。本研究的目的是使用与 Microsoft Kinect 传感器(Motorgame)相连的计算机应用程序来测量与抗精神病药物引起的帕金森病相关的运动模式,该程序应用于年轻的精神病患者,这些患者正在接受或刚接受抗精神病药物治疗。
所有参与者均接受神经系统检查、临床副作用评定量表(Udvalg for Kliniske Undersøgelser Side Effect Rating Scale、Barnes 静坐不能评定量表、Simpson Angus 量表和不自主运动量表)和 Motorgame 评估。此外,还评估了信息处理速度和Brief Assessment of Cognition in Schizophrenia 测试组合中的运动速度的子测试。
我们纳入了 21 名首发精神病的青少年(62%接受抗精神病药物治疗;男性占 38%;平均年龄 16±1.4 岁)和 69 名健康对照者(男性占 36%;平均年龄 16±1.5 岁)。Motorgame 中的运动表现延长时间(TOMP)与 SAS 中手臂下垂评分较高(p=0.009)相关。发现了一致的练习效应(p<0.001)。我们没有发现 TOMP 与年龄、身高、体重、性别、抗精神病药物剂量或信息处理速度之间存在显著相关性。
我们发现未经校正的 TOMP 与肩部运动迟缓之间存在显著关联。Motorgame 可用于评估早期精神病患者的帕金森症状,并得到参与者的认可。需要进行更大队列的未来研究,包括临床运动副作用量表评分较高的患者,以确定该新测试的有效性。